Association of Genetic Polymorphisms of N-Acetyltransferase 2 and Susceptibility to Esophageal Cancer in North Indian Population

REFERENCES

• Tew W. P., Kelsen D. P., Ilson D. H. Targeted therapies for esophageal cancer. Oncologist 2005; 10(8)590–601
   PubMed Web of Science ®Google Scholar
• Li F. P., Shiang E. L. Cancer mortality in China. J. Natl. Cancer Inst. 1980; 65(2)217–221
   PubMed Web of Science ®Google Scholar
• Khuroo M. S., Zargar S. A., Mahajan R., Banday M. A. High incidence of esophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 1992; 33(1)11–15
   PubMed Web of Science ®Google Scholar
• Butler L. M., Sinha R., Millikan R. C., Martin C. F., Newman B. G., et al. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am. J. Epidemiol. 2003; 157(5)434–445
   PubMed Web of Science ®Google Scholar
• Feng Z., Hu W., Rom W. N., Beland F. A., Tang M. S. 4-aminobiphenyl is a major etiological agent of human bladder cancer: evidence from its DNA binding spectrum in human p53 gene. Carcinogenesis 2002; 23(10)1721–1727
   PubMed Web of Science ®Google Scholar
• Marcus P. M., Hayes R. B., Vineis P., Garcia-Closas M., Caporaso N. E., et al. Cigarette smoking, N−acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol. Biomarkers Prev. 2000; 9(5)461–467
   PubMed Web of Science ®Google Scholar
• Yang C., Matsuo K., Wang Z., Tajima K. Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature. World J. Gastroenterol. 2005; 11(17)2531–2538
   PubMed Web of Science ®Google Scholar
• Garte S., Gaspari L., Alexandrie A. K., Ambrosone C., Autrup H., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 2001; 10(12)1239–1248
   PubMed Web of Science ®Google Scholar
• Meyer U. A., Zanger U. M. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu. Rev. Pharmacol. Toxicol. 1997; 37: 269–296
   PubMed Web of Science ®Google Scholar
• Morita S., Yano M., Tsujinaka T., Ogawa A., Taniguchi M., et al. Association between genetic polymorphisms of glutathione-S-transferase P1 and N-acetyltransferase 2 and susceptibility to squamous-cell carcinoma of the esophagus. Int. J. Cancer 1998; 79(5)517–520
   PubMed Web of Science ®Google Scholar
• Lee J. M., Lee Y. C., Yang S. Y., Shi W. L., Lee C. J., et al. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int. J. Cancer 2000; 89(5)458–464
   PubMed Web of Science ®Google Scholar
• Bell D. A., Taylor J. A., Butler M. A., Stephens E. A., Wiest J., et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993; 14(8)1689–1692
   PubMed Web of Science ®Google Scholar
• Cascorbi I., Brockmoller J., Mrozikiewicz P. M., Muller A., Roots I. Arylamine N-acetyltransferase activity in man. Drug Metab. Rev. 1999; 31(2)489–502
   PubMed Web of Science ®Google Scholar
• Gross M., Kruisselbrink T., Anderson K., Lang N., McGovern P., Delongchamp R., Kadlubar F. Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. Cancer Epidemiol. Biomarkers Prev. 1999; 8(8)683–692
   PubMed Web of Science ®Google Scholar
• Rothman N., Stewart W. F., Caporaso N. E., Hayes R. B. Misclassification of genetic susceptibility biomarkers: implications for case-control studies and cross-population comparisons. Cancer Epidemiol. Biomarkers Prev. 1993; 2(4)299–303
   PubMed Web of Science ®Google Scholar
• Deitz A. C., Rothman N., Rebbeck T. R., Hayes R. B., Chow W. H., et al. Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer. Cancer Epidemiol. Biomarkers Prev. 2004; 13(9)1543–1546
   PubMed Web of Science ®Google Scholar
• Arylamine N-acetyltransferase nomenclature committee. Arylamine N-Acetyltransferase (NAT) nomenclature, http://www.louisville.edu/medschool/pharmacology/NAT.html Available online at, (accessed 14 March, 2006)
   Google Scholar
• Windmill K. F., McKinnon R. A., Zhu X., Gaedigk A., Grant D. M., McManus M. E. The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies. Mutat. Res. 1997; 376(1–2)153–160
   PubMed Web of Science ®Google Scholar
• Windmill K. F., Gaedigk A., Hall P. M., Samaratunga H., Grant D. M., McManus M. E. Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol. Sci. 2000; 54(1)19–29
   PubMed Web of Science ®Google Scholar
• Grant D. M., Blum M., Beer M., Meyer U. A. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 1991; 39(2)184–191
   PubMed Web of Science ®Google Scholar
• Grant D. M., Hughes N. C., Janezic S. A., Goodfellow G. H., Chen H. J., et al. Human acetyltransferase polymorphisms. Mutat. Res. 1997; 376(2)61–70
   PubMed Web of Science ®Google Scholar
• Deguchi T., Mashimo M., Suzuki T. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J. Biol. Chem. 1990; 265(22)12757–12760
   PubMed Web of Science ®Google Scholar
• Hickman D., Sim E. N-acetyltransferase polymorphism. comparison of phenotype and genotype in humans. Biochem. Pharmacol. 1991; 42(5)1007–1014
   Google Scholar
• Shibuta J., Eto T., Kataoka A., Inoue H., Ueo H., et al. Genetic polymorphism of N-acetyltransferase 2 in patients with esophageal cancer. Am. J. Gastroenterol. 2001; 96(12)3419–3424
   PubMed Web of Science ®Google Scholar
• Khoury M. J., Flanders W. D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am. J. Epidemiol. 1996; 144(3)207–213
   Web of Science ®Google Scholar
• Greenland S. The effect of misclassification in the presence of covariates. Am. J. Epidemiol. 1980; 112(4)564–569
   PubMed Web of Science ®Google Scholar
• Morita M., Kuwano H., Yasuda M., Watanabe M., Ohno S., et al. The multicentric occurrence of squamous epithelial dysplasia and squamous cell carcinoma in the esophagus. Cancer 1994; 74(11)2889–2895
   PubMed Web of Science ®Google Scholar
• Hein D. W. Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta 1988; 948(1)37–66
   PubMed Web of Science ®Google Scholar
• Parent M. E., Siemiatycki J., Fritschi L. Workplace exposures and oesophageal cancer. Occup. Environ. Med. 2000; 57(5)325–334
   PubMed Web of Science ®Google Scholar
• Mumford J. L. Human exposure and dosimetry of polycyclic aromatic hydrocarbons in urine from Xuan Wei, China with high lung cancer mortality associated with exposure to unvented coal smoke. Carcinogenesis 1995; 16(12)30–31
   Google Scholar